News
Chrissy Teigen Stores Cord Blood & Tissue for her new baby"As part of my pregnancy, I learned banking my baby's newborn stem cells gives us access to current treatments and future clinical therapies, if my child ever needs them. We knew this was something we wanted to do – as a mom, I want to make sure our children have every possible option available to them."
Cell Care Joins the Generate Life Sciences Family to Create a Global PlatformCell Care, Australia’s leading cord blood bank, today announced it has been acquired by Generate Life Sciences (Generate). Generate operates Cord Blood Registry (CBR), North America’s largest cord blood bank and one of the world’s preeminent stem cell R&D organisations.
Generate joins CooperSurgical, advancing the health of women, babies and familiesIn November 2021 it was announced that CooperCompanies acquired Generate Life Sciences under its CooperSurgical banner. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics.
Umbilical cord mesenchymal stem cells used for COVID-19 trialDoctors in Florida say a clinical trial using stem cells from cord tissue has been incredibly successful in treating patients with severe cases of COVID-19. Patients from Jackson Memorial Hospital and the University Miami Tower are involved, with many of them with acute respiratory distress syndrome (ARDS).
Ash Pollard chooses to store her baby’s stem cells with Cell CareAsh Pollard needs no introduction. After announcing her pregnancy earlier in the year, we are excited that Ash has decided to store her baby’s cord blood and tissue with Cell Care. Ash attended a Tummy Talks antenatal class and this is where she heard about cord blood banking. Listen to the discussion between Midwife Cath..
Covid-19 Cord Blood TrialChannel 7 News have reported cord blood-derived cells are being used in a world first clinical trial to treat COVID-19.
Monash University and Monash Health are undertaking the trial for severe COVID-19 patients who are anticipated to improve within 24 hours of cord blood treatment.
COVID-19 and Umbilical Cord TissueThe impact of COVID-19 is being felt worldwide and there is a tremendous amount of research being undertaken to understand this disease, prevent its transmission, and treat those infected. Patients with COVID-19 can present with little to no symptoms, cold or flu like symptoms, or in severe cases, can progress to pneumonia, sometimes leading to death.
COVID-19 UpdateAs the potential consequences of the coronavirus (COVID-19) are felt across many aspects of our lives, we’re reaching out to update our client families. We want to anticipate potential questions regarding the impact of the virus on cord blood collection, storage and therapeutic use.
Have you considered cord blood banking as a gift for your grandchildren?You’ve nurtured and prepared your children to be happy and healthy adults. Now they’re grown up with children of their own arriving, there’s different, long lasting support you can provide.
Cord Blood Expansion Technology May Help Patients With Blood Cancers Like LeukaemiaThere have been some exciting developments in a clinical trial investigating expanded cord blood for the treatment of blood cancers including leukemia.
BREAKING NEWS: Placental stem cell research into stroke therapy takes promising step forwardAustralian pre-clinical research has established through trials on mice that systematic administration of placental stem cells, after ischaemic stroke, stimulates significant neuroprotection and facilitates brain recovery and repair.
Breakthrough cord blood therapy for children with neurological disordersChildren with various brain disorders who have their own or a sibling’s cord blood stored in a family bank may now be able to receive cord blood therapy regardless of whether they qualify for a targeted clinical trial...
Children with Hypoplastic Left Heart Syndrome Receive Cord BloodThis collaborative cord blood stem cell research will assist the determination of the safety and feasibility of injections of autologous umbilical cord blood stem cells into the right ventricle of children with Hypoplastic Left Heart Syndrome ...
Promising autism research using cord blood and cord tissueAutism research using cord blood has been advanced in recent times by studies at Duke University, North Carolina and Shandong Jiaotong Hospital, China. With over 1 in 100 children in Australia diagnosed with autism...
Advances in cord blood expansion technologiesCord blood expansion focuses on the ability to expand the number of cells derived from a cord blood collection. An expanded cord blood unit can further boost utility in both current and future medical uses...
Choosing Between Cord Blood Donation & Family Cord BankingPrior to your child’s birth, there are a number of important decisions to make, including choosing what to do with their cord blood. There are essentially two stem cell storage options available to expectant parents…
New Cord Blood Research Shows Improvements in Cerebral PalsyA Duke University clinical trial has found the use of umbilical cord blood stem cells increases motor function and brain connectivity in children with cerebral palsy (CP).
30 Years of Cord Blood Stem Cell TreatmentsOctober 2018 marked 30 years since Matthew Farrow, a 5-year old boy with Fanconi anemia received treatment using his newborn sister’s umbilical cord blood in the world’s first cord blood transplant. Since then, cord blood stem cells have been used…
Cell Care joins with Insception Biosciences Inc. to Establish Global Platform.Cell Care, Australia’s largest cord blood & tissue bank has announced it has acquired Insception Lifebank, Canada’s largest private cord blood & tissue bank. The combined entity creates one of the world’s top 10 companies in the sector.